- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03626532
Mind-body Interventions for Healthy Aging (HealthyAgers)
August 29, 2023 updated by: Ruchika Prakash, Ohio State University
The goal of this study is to examine the impact of mind-body interventions in enhancing behavioral and neural correlates of attentional control in older adults.
Participants will be randomized to either a 8-week mindfulness meditation group or a 8-week lifestyle education group.
Additional booster sessions, spanning the course of a year, will be offered to participants in both groups.
Participants will complete pre- and post-assessments of neurocognitive and emotional functioning, and will be assessed for maintained benefits 12-months post-intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Mind-body interventions are increasingly being examined for their potential to improve cognitive function, enhance emotion regulation, reduce stress and related inflammatory markers, and alter the neural circuitry supporting cognitive and emotional functioning.
The primary goal of this study is to examine changes in attentional control resulting from engaging in mind-body interventions with additional booster sessions over the course of a year.
Within this goal, the behavioral and neural mechanisms of change in attentional control will be investigated and the transfer of benefits to performance on measures of everyday cognition and emotion regulation will be assessed.
Our main hypothesis is that eight weeks of mindfulness training will increase attentional control performance in the elderly, partially through mindfulness-induced reductions in mind-wandering and changes in the functional architecture of the brain.
Up to 200 older adults (ages 65-85) will be enrolled for the study.
Of these, 151 older adults meeting eligibility criteria will be randomized to either an eight-week MBSR (mindfulness based stress reduction) program or a lifestyle education group.
Participants will attend weekly mindfulness training or lifestyle education sessions and will be asked to complete homework assignments administered via a mobile/web-based application designed by the laboratory.
All participants will also be invited to participate in four booster sessions over the course of 12 months following the intervention with continued access to the mobile application content.
Behavioral metrics of cognitive function and inflammatory markers will be collected before and after the eight-week intervention as well as at 6-months and 12-month follow-up assessments.
Neural metrics of cognitive functioning will be collected before and after the eight-week intervention as well as at 12-month follow-up assessments.
Study Type
Interventional
Enrollment (Actual)
173
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Department of Psychology, The Ohio State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 85 years (Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Between ages 65-85 years
- Capable of attending the assessment and the majority of intervention sessions
- Right-handed
- Fluent English speaker
- Corrected (near and far) visual acuity of 20/40 or better
- Normal color vision
- Adequate hearing for experimental purposes
- Absence of diagnosed terminal illness
- Absence of diagnosed neurological disorders
- No history of psychotic disorder or substance abuse disorder
- Absence of any psychiatric disorder that was 1) diagnosed by a psychologist or psychiatrist and 2) diagnosed within the past 2 years OR symptoms and/or treatment is ongoing
- Score less than 20 on the Center for Epidemiologic Studies Depression Scale (CES-D)
- Absence of medication use that significantly alters brain activity
- No history of diagnosed learning disability that would interfere with the completion of cognitive tasks
- No evidence of dementia: No scores below 2 standard deviations from the mean on neuropsychological battery AND adequate self-reported performance of instrumental activities of daily living
- To be included in the MRI portion of the study (not exclusionary for study participation): Absence of any non-MRI safe objects that cannot be removed, not pregnant and not attempting to become pregnant, and absence of self-reported claustrophobia
- Able to engage in light stretching exercises with or without assistive devices
- No regular practice of meditation or yoga (defined as once or more per week) AND no previous participation in a structured mindfulness class such as MBSR
- Access to the internet
Exclusion Criteria:
- Not between the ages of 65-85
- Any physical limitation or pragmatic limitation that prohibits attendance at assessment sessions and intervention sessions
- Left-handed or ambidextrous
- No fluency in English
- Corrected (near or far) visual acuity worse than 20/40
- All types of color blindness
- Self-reported hearing impairment that would affect their ability to hear the experimenter
- Diagnosis of terminal illness
- Presence of diagnosed neurological disorders
- History of psychotic disorder or substance abuse disorder diagnosed by a psychologist or psychiatrist
- History of psychotic disorder or substance abuse disorder diagnosed by a psychologist of psychiatrist
- Presence of any psychiatric disorder that was 1) diagnosed by a psychologist or psychiatrist and 2) diagnosed within the past 2 years OR symptoms/treatment is on going
- Score greater than or equal to 20 on the CES-D
- Medication use that significantly alters brain activity
- History of diagnosed learning disability that would interfere with completion of the cognitive tasks
- Evidence of dementia: one or more memory scores below 2 standard deviations from the mean AND one or more non-memory scores below 2 standard deviations from the mean on neuropsychological battery OR total score below 2 standard deviations from the mean on neuropsychological battery OR inadequate self-reported performance of instrumental activities of daily living
- Presence of non-MRI safe objects that cannot be removed, pregnant or attempting to become pregnant, or self-reported claustrophobia (exclusionary for MRI portion of the study only)
- Actual or perceived limitation that prohibits engaging in light stretching exercises with or without assistive devices
- Any regular practice of meditation or yoga (defined as once or more per week) OR previous participation in a structured mindfulness class such as MBSR
- No access to the internet
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness-Based Stress Reduction
Participants will meet once a week for 8 weeks (2.5 hours per session), plus a 4-hour retreat day, to engage in mindfulness meditation exercises.
Didactic components will include oral presentations, informational videos, and group discussion.
Additionally, daily homework assignments will require participants to engage in guided practices for 30 minutes a day for 5 days a week.
|
The MBSR program is a mind-body approach developed by Kabat-Zinn to reduce pain and stress through mindfulness meditation.
MBSR is a form of mental training characterized by the self-regulation of attention and focal orientation to present moment experiences.
Mindfulness practice is thought to effectively promote emotional and cognitive control.
Mindfulness includes directing awareness away from thoughts, emotions and sensations towards some specific "anchor" to the present, such as the breath.
Participants will engage in various practices including breath awareness, body scans, mindful listening, etc.
Other Names:
|
Active Comparator: Lifestyle Education
Participants will meet once a week for 2.5 hours for 8 weeks, plus a 4-hour retreat day, to engage in light stretching exercises and interactive discussions on health topics, such as physical activity, nutrition, sleep, stress, etc. Didactic components will include oral presentations, informational videos, and group discussion.
Additionally, daily homework assignments will ask participants to engage in stretching, read or watch informational content, and answer reflection questions for 30 minutes a day for 5 days a week.
|
This group will engage in light stretching exercises at each session.
They will also be provided with information drawn from the scientific literature on topics related to healthy aging, including physical activity, sedentary behavior, nutrition, hydration, stress, sleep, and cognitively stimulating activities.
Group discussion will be incorporated throughout.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in attentional control on tasks of sustained attention
Time Frame: Baseline, 2 months, 8 months, 14 months
|
Participants will complete computerized measures of Continuous Performance Test and Go/No-Go Task to assess sustained attention.
Detectability (d') measures will be calculated to assess the effects of mind-body interventions on attentional control.
Data collected at 8-months and 14-month will be used to determine maintenance effects.
|
Baseline, 2 months, 8 months, 14 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in neural functioning during measures of attentional control
Time Frame: Baseline, 2 months, 14 months
|
Participants will complete an functional magnetic resonance imaging (fMRI) assessment before and after the intervention.
Functional connectivity changes will be examined during tasks of attentional control to determine neural correlates of mind-body interventions.
|
Baseline, 2 months, 14 months
|
Change in mind-wandering on tasks of sustained attention
Time Frame: Baseline, 2 months, 8 months, 14 months
|
To measure mind-wandering, participants will also be prompted with quasi-random probes asking them to categorize the thoughts they were having immediately preceding the probe.
|
Baseline, 2 months, 8 months, 14 months
|
Change in emotion regulation strategy sse
Time Frame: Baseline, 2 months, 8months, 14 months
|
Participants will complete lab-based and ecological momentary assessment (EMA)-based emotion regulation strategy use tasks to determine change in ER strategy use following mind-body interventions.
|
Baseline, 2 months, 8months, 14 months
|
Change in cognitive performance on the NIH Cognitive Toolbox Battery
Time Frame: Baseline, 2 months, 8 months, 14 months
|
Participants will perform the NIH Cognitive Toolbox Battery comprised of seven different tasks aimed at measuring episodic memory, executive function, attention, working memory, language, and processing speed.
Change on this measure will be assessed to determine the impact of the mind-body interventions on various domains of cognitive functioning.
|
Baseline, 2 months, 8 months, 14 months
|
Change in Measure of Daily Functioning
Time Frame: Baseline, 2 months, 8 months, 14 months
|
Participants will complete the Driving Scenes subtest of the Neuropsychological Assessment Battery (NAB) as a measure of everyday cognition.
This subtest measures attention and working memory to changing driving scenes.
|
Baseline, 2 months, 8 months, 14 months
|
Change in inflammatory biomarkers
Time Frame: Baseline, 2 months, 8 months, 14 months
|
Data on inflammatory markers - C-reactive protein (CRP), interleukin 6 (IL-6), and interleukin 10 (IL-10) - will be collected to determine the impact of mind-body interventions on systemic markers of inflammation.
|
Baseline, 2 months, 8 months, 14 months
|
Change in self-report measures of stress
Time Frame: Baseline, 2 months, 8 months, 14 months
|
Participants will be administered the Perceived Stress Scale (PSS) to measure changes in self-reported perceived stress following mind-body interventions.
This measure has 10 items, each measured on a 5-point rating scale.
One total score will be calculated by summing the individual item responses.
Higher scores represent greater feelings of stress, unpredictability, and uncontrollability.
|
Baseline, 2 months, 8 months, 14 months
|
Change in self-report measures of emotion dysregulation
Time Frame: Baseline, 2 months, 8 months, 14 months
|
Participants will be administered the Difficulties in Emotion Regulation Scale (DERS) to examine changes in degree of self-reported emotion dysregulation following mind-body interventions.
This measure has 36 items, each measured on a 5-point rating scale.
One total score will be calculated by summing the individual item responses.
Higher scores represent greater perceived difficulties in emotion regulation capabilities.
|
Baseline, 2 months, 8 months, 14 months
|
Change in self-report measures of quality of life
Time Frame: Baseline, 2 months, 8 months, 14 months
|
Participants will be administered the The World Health Organization Quality of Life abbreviated scale (WHOQOL-BREF) to examine changes in self-reported quality of life following mind-body interventions.
This measure has 26 items, each measured on a 5-point rating scale.
Four domains are measured by taking the average of representative items: psychological (six items), environmental (eight items), physical health (seven items), and social relationships (three items), as well as overall QoL (two items).
Higher scores represent better perceived quality of life.
|
Baseline, 2 months, 8 months, 14 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ruchika Prakash, Ph.D., The Ohio State Universty
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 17, 2018
Primary Completion (Actual)
August 22, 2022
Study Completion (Actual)
July 24, 2023
Study Registration Dates
First Submitted
August 4, 2018
First Submitted That Met QC Criteria
August 8, 2018
First Posted (Actual)
August 13, 2018
Study Record Updates
Last Update Posted (Actual)
August 31, 2023
Last Update Submitted That Met QC Criteria
August 29, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2017H0223
- R01AG054427 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Amazentis SAproDERM GmbHCompleted
-
Northumbria UniversityUniversity of East AngliaSuspendedSleep | Aging | Healthy AgingUnited Kingdom
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
Clinical Trials on Mindfulness-Based Stress Reduction (MBSR)
-
Duke UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Inflammation | Stress, Psychological | SleepUnited States
-
Ottawa Hospital Research InstituteCanadian Cancer Society (CCS)CompletedCancer | Chronic Pain | Painful Neuropathy | Worries; Pain or DisabilityCanada
-
University of AarhusCopenhagen University Hospital, HvidovreCompletedAn Adapted Mindfulness-based Stress Reduction Program for Psycho-socially Vulnerable Pregnant Women.Pregnancy, High RiskDenmark
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)RecruitingArthritis, RheumatoidUnited States
-
University of SheffieldCompleted
-
Northwestern UniversityAmerican Cancer Society, Inc.; Robert H. Lurie Cancer CenterCompleted
-
Universität Duisburg-EssenMinisterium für Schule und Weiterbildung, Land Nordrhein-Westfalen; Ministerium...CompletedChild Development | Burnout Syndrome | MindfulnessGermany
-
National Taiwan University HospitalUnknownMindfulness-based Stress ReductionTaiwan
-
University of ManitobaWorkers Compensation Board of Manitoba; Catholic Health Corporation of ManitobaUnknownBurnout, Professional | Emotional Stress | Work Related Illnesses | Burnout SyndromeCanada
-
University Medical Center GroningenCompletedOvarian CancerNetherlands